Leica Biosystems is a medical devices company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company as well as a division of Danaher Corporation.

Leica Biosystems

American Pathology Partners no longer provides laboratory or pathology services after selling its operations in multiple states.

American Pathology Partners

Beckman Coulter Diagnostics provides products and services in the fields of clinical diagnostics, including chemistry, immunoassay, hematology, urinalysis, and microbiology. They focus on laboratory automation and informatics solutions.

Beckman Coulter Diagnostics

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Florence Kurth

Florenz Sartorius

Sartorius Aktiengesellschaft

Danaher Corporation

Leica Biosystems is proud to be part of Danaher.

Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.


--

Leica Biosystems Privacy Policy can be found at: https://www.leicabiosystems.com/about/privacy-policy/

The collection, storage, use, disclosure, retention and destruction of data on this page, including any personal data, are all subject, as applicable, to Leica Biosystems’ Terms of Use and Privacy Policy. We do not endorse or approve user generated content to promote any other use of our products and will remove any comments or references to such off-label use. We reserve the right to remove a topic or comment at our discretion.

By accessing the content, you expressly acknowledge and agree: (1) the content is provided only as a convenience to you and you are accessing the content for your personal educational purposes only; (2) the content may be from a variety of sources over which Leica Biosystems has no control, and should therefore not be interpreted as representing the opinions of, or an endorsement by, Leica Biosystems or its associates; (3) the content is provided to you AS IS, and you release Leica Biosystems of any responsibility or damages you may suffer as a result of the content, including without limitation, any damages resulting from the inaccuracy or unsuitability of the content.

#WebinarWednesday 
Tune in TODAY at 12 noon EST to unlock the secrets of precision in cryosectioning with Marla Rivera-Oliver, Ph.D. Learn how to properly prepare tissue, an essential but often overlooked element of cryosectioning, and achieve better cryosectioning outcomes in the research environment. Dive into essential techniques and Histology Hacks for optimal outcomes. 

Register today: https://ow.ly/KVim50Qw59F #Research #HistologyHacks Labroots #valentinesday

Robin Fitzl, Sr App Specialist at Leica Biosystems, answers real questions from practitioners in research laboratories worldwide. Robin answers your most challenging tissue-processing dilemmas as part of her popular “Lessons from the Laboratory” series.

 https://ow.ly/KrTA50PAz9I

Did you know that you can earn continuing education credits for viewing content on Knowledge Pathway? Our educational portal has editorials, webinars, training resources, and more. Check it out now! http://ow.ly/CeoI50FTDFk  #pathology

Metric
Company Name	Leica Biosystems	American Pathology Partners	Beckman Coulter Diagnostics	Sartorius Aktiengesellschaft
Symbol				SRT
MSH ID	COM:LEICABIOSYSTEMS	COM:AP2	COM:BECKMANCOULTER	COM:SARTORIUS
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Biotechnology	Health Services	Diagnostic Equipment and Supplies	Medical - Instruments & Supplies
Country	DE	US	US	DE
Stage
Employee Count	2.36K	251		14.61K
Website	leicabiosystems.com	ap2.com	beckmancoulter.com	sartorius.com
LinkedIn	leica-biosystems			sartorius
Founders

Metric
Market Cap			15.56B
Enterprise Value
Monthly Web Traffic	208.90K	386.71K	1.07M
Web Traffic Growth	0.06	0.41	1.47
Valuation
Raised Capital

Metric
Revenue				3.59B
Revenue (LTM)
Revenue (NTM)
Gross Profit				1.66B
EBITDA				890.51M
Operating Income				528.96M
Net Income				357.53M
EPS				5.23
Diluted EPS				5.23
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.46
Operating Profit Margin				0.16
EBITDA Margin				0.25
Net Profit Margin				0.09
Return on Equity				0.15
Return on Assets				0.03
Return on Capital Employed				0.07

COM:LEICABIOSYSTEMS

Leica Biosystems

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				41.01
P/B Ratio				8.67
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				6.48
EV Multiple				19.08

Metric
Days Sales Outstanding				42.10
Days Payables Outstanding				91.49
Days Inventory Outstanding				206.95
Operating Cycle				260.52
Cash Conversion Cycle				181.83
Asset Turnover				0.35

Metric
Operating Cash Flow				901.60M
Free Cash Flow				310.43M
Cash Flow to Debt				0.18
Operating Cash Flow/Sales				0.25
Free Cash Flow Yield				0.01

Metric
Cash & Equivalents				400.52M
Accounts Receivable				178.08M
Inventory				1.10B
Goodwill				3.61B
Debt to Capitalization				0.72
Debt to Assets				0.54
Current Ratio				1.49
Quick Ratio				1.19

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue				0.05
SG&A to Revenue				0.05